GlassScriptPhysician profile
Ahsan Sattar
NPI 1154551554
$6,767.33
in general payments reported to CMS, 2019-2025
14 companies · $886 in 2025
The $886 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $818 · 2020: $178 · 2021: $103 · 2022: $1,150 · 2023: $3,100 · 2024: $532 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,475 · Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,475.00 |
| Food and Beverage | $2,042.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaneka Medical America LLC | $2,475.00 | 2023 | |
| Imperative Care, INC | $1,152.78 | 2022-2025 | Symphony Catheter, Zoom Reperfusion Catheter |
| Medtronic, INC. | $721.75 | 2022-2025 | Pipeline, Solitaire X, Axium Primetm |
| Stryker Corporation | $721.43 | 2019-2025 | Surpass Evolve |
| Qapel Medical INC | $429.02 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $321.88 | 2020-2023 | Artis Icono Biplane |
| Medtronic USA, INC. | $245.52 | 2019-2020 | |
| Penumbra, INC. | $175.44 | 2019 | |
| Edwards Lifesciences Corporation | $119.02 | 2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $117.28 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $113.96 | 2023 | Breztri |
| Globus Medical, INC. | $104.45 | 2025 | Senza |
| Cardinal Health 200 LLC | $39.62 | 2019 | |
| Microvention, INC. | $30.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahsan Sattar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.